Vanda Pharmaceuticals (VNDA) EPS (Basic) (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported EPS (Basic) of -$0.82 for Q1 2026, down 61.94% on a YoY basis from -$2.14 in Q1 2025, and up 65.94% sequentially from -$2.4 in Q4 2025.
Vanda Pharmaceuticals (VNDA) EPS (Basic) (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of EPS (Basic) data on file, last reported at -$0.82 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 61.94% year-over-year to -$0.82; the trailing twelve-month figure through Mar 2026 stood at -$4.03 (down 432.95% YoY), and the FY2025 full-year result was -$3.74, down 1051.07% from the prior year.
- EPS (Basic) rose to -$0.82 in Q1 2026, from -$2.4 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.12 in Q4 2022 to a low of -$2.4 in Q4 2025.
- A 5-year average of -$0.28 and a median of -$0.08 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 149.14% in 2023 and plunged 3950.99% in 2024, its largest moves.
- Tracing VNDA's EPS (Basic) over 5 years: stood at $0.12 in 2022, then tumbled by 134.29% to -$0.04 in 2023, then tumbled by 101.24% to -$0.08 in 2024, then sank by 2757.17% to -$2.4 in 2025, then surged by 65.94% to -$0.82 in 2026.
- Business Quant data shows VNDA's EPS (Basic) at -$0.82 in Q1 2026, -$2.4 in Q4 2025, and -$0.38 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Vanda Pharmaceuticals | 309.49 Mn | 107.18 Mn | 48.56 Mn | -0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -2.40 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | -0.08 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | 0.13 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.17 |